Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_001323289.2(CDKL5):c.469G>C (p.Ala157Pro)

CA412352120

1387019 (ClinVar)

Gene: CDKL5 (HGNC:6792)

Condition: CDKL5 disorder (MONDO:0100039)

Inheritance Mode: X-linked inheritance

UUID: 66d37eeb-e461-41c1-b2d6-4c2179e29b0a

Approved on: 2023-10-13

Published on: 2023-12-11

HGVS expressions

NM_001323289.2(CDKL5):c.469G>C (p.Ala157Pro)

NM_001323289.2:c.469G>C

NC_000023.11:g.18584268G>C

CM000685.2:g.18584268G>C

NC_000023.10:g.18602388G>C

CM000685.1:g.18602388G>C

NC_000023.9:g.18512309G>C

NG_008475.1:g.163664G>C

ENST00000623535.2:c.469G>C

ENST00000635828.1:c.469G>C

ENST00000637881.1:c.469G>C

ENST00000674046.1:c.469G>C

ENST00000379989.6:c.469G>C

ENST00000379996.7:c.469G>C

ENST00000463994.4:c.469G>C

ENST00000623535.1:c.469G>C

NM_001037343.1:c.469G>C

NM_003159.2:c.469G>C

NM_001323289.1:c.469G>C

NM_001037343.2:c.469G>C

NM_003159.3:c.469G>C

Likely Pathogenic

PM2_Supporting PP3 PM5 PS2

PM1

Evidence Links 0

Expert Panel

Rett and Angelman-like Disorders VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Rett and Angelman-like Disorders VCEP

The p.Ala157Pro variant in CDKL5 has been reported as a de novo occurrence (biological parentage confirmed) in an individual with clinical features of CDKL5 disorder (internal database - Invitae) (PS2). A pathogenic missense variant (p.Ala157Val) has been previously identified within this codon which indicates that this residue is critical to the function of the protein (ClinVar - ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel) (PM5). The p.Ala157Pro variant in CDKL5 is absent from gnomAD (PM2_Supporting). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). In summary, the p.Ala157Pro variant in CDKL5 is classified as Likely Pathogenic for CDKL5 disorder based on the ACMG/AMP criteria (PS2, PM5, PM2_Supporting, PP3).

PM2_Supporting

The p.Ala157Pro variant in CDKL5 is absent from gnomAD (PM2_Supporting).

PP3

Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3).

PM5

A pathogenic missense variant (p.Ala157Val) has been previously identified within this codon which indicates that this residue is critical to the function of the protein (ClinVar - ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel) (PM5).

PS2

PM1

No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.